Bird Rock Bio's Series B Round

Bird Rock Bio raised a round of funding on March 27, 2014.

Bird Rock Bio, formerly RuiYi, is a clinical stage biopharmaceutical company focused on developing immuno-inflammatory regulators. The company's strategy leverages biologic targets with substantial hu…

Articles about Bird Rock Bio's Series B Round: